<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34234251</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>07</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Clinical characterization of dysautonomia in long COVID-19 patients.</ArticleTitle><Pagination><StartPage>14042</StartPage><MedlinePgn>14042</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">14042</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-93546-5</ELocationID><Abstract><AbstractText>Increasing numbers of COVID-19 patients, continue to experience symptoms months after recovering from mild cases of COVID-19. Amongst these symptoms, several are related to neurological manifestations, including fatigue, anosmia, hypogeusia, headaches and hypoxia. However, the involvement of the autonomic nervous system, expressed by a dysautonomia, which can aggregate all these neurological symptoms has not been prominently reported. Here, we hypothesize that dysautonomia, could occur in secondary COVID-19 infection, also referred to as "long COVID" infection. 39 participants were included from December 2020 to January 2021 for assessment by the Department of physical medicine to enhance their physical capabilities: 12 participants with COVID-19 diagnosis and fatigue, 15 participants with COVID-19 diagnosis without fatigue and 12 control participants without COVID-19 diagnosis and without fatigue. Heart rate variability (HRV) during a change in position is commonly measured to diagnose autonomic dysregulation. In this cohort, to reflect HRV, parasympathetic/sympathetic balance was estimated using the NOL index, a multiparameter artificial intelligence-driven index calculated from extracted physiological signals by the PMD-200 pain monitoring system. Repeated-measures mixed-models testing group effect were performed to analyze NOL index changes over time between groups. A significant NOL index dissociation over time between long COVID-19 participants with fatigue and control participants was observed (p&#x2009;=&#x2009;0.046). A trend towards significant NOL index dissociation over time was observed between long COVID-19 participants without fatigue and control participants (p&#x2009;=&#x2009;0.109). No difference over time was observed between the two groups of long COVID-19 participants (p&#x2009;=&#x2009;0.904). Long COVID-19 participants with fatigue may exhibit a dysautonomia characterized by dysregulation of the HRV, that is reflected by the NOL index measurements, compared to control participants. Dysautonomia may explain the persistent symptoms observed in long COVID-19 patients, such as fatigue and hypoxia. Trial registration: The study was approved by the Foch IRB: IRB00012437 (Approval Number: 20-12-02) on December 16, 2020.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barizien</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Foch Hospital, Suresnes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Guen</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Foch Hospital, Suresnes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russel</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Foch Hospital, Suresnes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touche</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Research and Innovation, Foch Hospital, 40 rue Worth, 92150, Suresnes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Florent</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Foch Hospital, Suresnes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vall&#xe9;e</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Research and Innovation, Foch Hospital, 40 rue Worth, 92150, Suresnes, France. alexandre.g.vallee@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054969" MajorTopicYN="N">Primary Dysautonomias</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34234251</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-93546-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carf&#xec; A, Bernabei R, Landi Gemelli F, Against COVID-19 Post-Acute Care Study Group Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz, Y. M. J. et al. Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res.6, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin. Neurol. Neurosurg. 2020;194:105921. doi: 10.1016/j.clineuro.2020.105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.105921</ArticleId><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Duarte A, Norcliffe-Kaufmann L. Is &#x2018;happy hypoxia&#x2019; in COVID-19 a disorder of autonomic interoception? A hypothesis. Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc. 2020;30:331&#x2013;333. doi: 10.1007/s10286-020-00715-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00715-z</ArticleId><ArticleId IdType="pmc">PMC7362604</ArticleId><ArticleId IdType="pubmed">32671502</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshak N, et al. Dysautonomia: an overlooked neurological manifestation in a critically ill COVID-19 patient. Am. J. Med. Sci. 2020;360:427&#x2013;429. doi: 10.1016/j.amjms.2020.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.07.022</ArticleId><ArticleId IdType="pmc">PMC7366085</ArticleId><ArticleId IdType="pubmed">32739039</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin. Med. Lond. Engl. 2020 doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo YL. COVID-19, fatigue, and dysautonomia. J. Med. Virol. 2020 doi: 10.1002/jmv.26552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26552</ArticleId><ArticleId IdType="pubmed">32975809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K, Jamal S, Kichloo A, Grubb BP. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J. Innov. Card. Rhythm Manag. 2020;11:4302&#x2013;4304. doi: 10.19102/icrm.2020.111102.</Citation><ArticleIdList><ArticleId IdType="doi">10.19102/icrm.2020.111102</ArticleId><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinu P, et al. SARS CoV-2 organotropism associated pathogenic relationship of gut-brain axis and illness. Front. Mol. Biosci. 2020;7:606779. doi: 10.3389/fmolb.2020.606779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.606779</ArticleId><ArticleId IdType="pmc">PMC7783391</ArticleId><ArticleId IdType="pubmed">33415126</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdillon N, Yazdani S, Schmitt L, Millet GP. Effects of COVID-19 lockdown on heart rate variability. PLoS ONE. 2020;15:e0242303. doi: 10.1371/journal.pone.0242303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242303</ArticleId><ArticleId IdType="pmc">PMC7660489</ArticleId><ArticleId IdType="pubmed">33180839</ArticleId></ArticleIdList></Reference><Reference><Citation>Laborde S, Mosley E, Thayer JF. Heart rate variability and cardiac vagal tone in psychophysiological research&#x2014;recommendations for experiment planning, data analysis, and data reporting. Front. Psychol. 2017;8:213. doi: 10.3389/fpsyg.2017.00213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2017.00213</ArticleId><ArticleId IdType="pmc">PMC5316555</ArticleId><ArticleId IdType="pubmed">28265249</ArticleId></ArticleIdList></Reference><Reference><Citation>Swai J, Hu Z, Zhao X, Rugambwa T, Ming G. Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis. BMC Cardiovasc. Disord. 2019;19:320. doi: 10.1186/s12872-019-01298-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-019-01298-y</ArticleId><ArticleId IdType="pmc">PMC6936126</ArticleId><ArticleId IdType="pubmed">31888497</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzman JB, Bridgett DJ. Heart rate variability indices as bio-markers of top-down self-regulatory mechanisms: A meta-analytic review. Neurosci. Biobehav. Rev. 2017;74:233&#x2013;255. doi: 10.1016/j.neubiorev.2016.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2016.12.032</ArticleId><ArticleId IdType="pubmed">28057463</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger JJ. Sympathovagal balance: how should we measure it? Am. J. Physiol. 1999;276:H1273&#x2013;1280.</Citation><ArticleIdList><ArticleId IdType="pubmed">10199852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Israel N, Kliger M, Zuckerman G, Katz Y, Edry R. Monitoring the nociception level: a multi-parameter approach. J. Clin. Monit. Comput. 2013;27:659&#x2013;668. doi: 10.1007/s10877-013-9487-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-013-9487-9</ArticleId><ArticleId IdType="pubmed">23835792</ArticleId></ArticleIdList></Reference><Reference><Citation>Denisko D, Hoffman MM. Classification and interaction in random forests. Proc. Natl. Acad. Sci. U. S. A. 2018;115:1690&#x2013;1692. doi: 10.1073/pnas.1800256115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800256115</ArticleId><ArticleId IdType="pmc">PMC5828645</ArticleId><ArticleId IdType="pubmed">29440440</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt L, Regnard J, Millet GP. Monitoring fatigue status with HRV measures in elite athletes: an avenue beyond RMSSD? Front. Physiol. 2015;6:343. doi: 10.3389/fphys.2015.00343.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2015.00343</ArticleId><ArticleId IdType="pmc">PMC4652221</ArticleId><ArticleId IdType="pubmed">26635629</ArticleId></ArticleIdList></Reference><Reference><Citation>Saboul D, Pialoux V, Hautier C. The impact of breathing on HRV measurements: implications for the longitudinal follow-up of athletes. Eur. J. Sport Sci. 2013;13:534&#x2013;542. doi: 10.1080/17461391.2013.767947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17461391.2013.767947</ArticleId><ArticleId IdType="pubmed">24050471</ArticleId></ArticleIdList></Reference><Reference><Citation>Uijen AA, et al. Nijmegen Continuity Questionnaire: development and testing of a questionnaire that measures continuity of care. J. Clin. Epidemiol. 2011;64:1391&#x2013;1399. doi: 10.1016/j.jclinepi.2011.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.03.006</ArticleId><ArticleId IdType="pubmed">21689904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashbaugh AR, Houle-Johnson S, Herbert C, El-Hage W, Brunet A. Psychometric Validation of the English and French Versions of the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) PLoS ONE. 2016;11:e0161645. doi: 10.1371/journal.pone.0161645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161645</ArticleId><ArticleId IdType="pmc">PMC5056703</ArticleId><ArticleId IdType="pubmed">27723815</ArticleId></ArticleIdList></Reference><Reference><Citation>Langhammer B, Stanghelle JK. Senior fitness test; a useful tool to measure physical fitness in persons with acquired brain injury. Brain Inj. 2019;33:183&#x2013;188. doi: 10.1080/02699052.2018.1540796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02699052.2018.1540796</ArticleId><ArticleId IdType="pubmed">30403880</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeanne M, Logier R, De Jonckheere J, Tavernier B. Heart rate variability during total intravenous anesthesia: effects of nociception and analgesia. Auton. Neurosci. Basic Clin. 2009;147:91&#x2013;96. doi: 10.1016/j.autneu.2009.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2009.01.005</ArticleId><ArticleId IdType="pubmed">19201661</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, W. et al. A Wearable Tele-Health System towards Monitoring COVID-19 and Chronic Diseases. IEEE Rev. Biomed. Eng.PP, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905615</ArticleId><ArticleId IdType="pubmed">33784625</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Lagos JJ, et al. A translational perspective of maternal immune activation by SARS-CoV-2 on the potential prenatal origin of neurodevelopmental disorders: the role of the cholinergic anti-inflammatory pathway. Front. Psychol. 2021;12:614451. doi: 10.3389/fpsyg.2021.614451.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.614451</ArticleId><ArticleId IdType="pmc">PMC8044741</ArticleId><ArticleId IdType="pubmed">33868085</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M, Le Coupanec A, Stodola JK, Meessen-Pinard M, Talbot PJ. Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis. Virus Res. 2014;194:145&#x2013;158. doi: 10.1016/j.virusres.2014.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.09.011</ArticleId><ArticleId IdType="pmc">PMC7114389</ArticleId><ArticleId IdType="pubmed">25281913</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam SB, Willows S, Kulka M, Sandhu JK. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Eur. J. Neurol. 2020;27:2348&#x2013;2360. doi: 10.1111/ene.14442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14442</ArticleId><ArticleId IdType="pmc">PMC7405269</ArticleId><ArticleId IdType="pubmed">32668062</ArticleId></ArticleIdList></Reference><Reference><Citation>Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020;58:299&#x2013;301. doi: 10.4193/Rhin20.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.114</ArticleId><ArticleId IdType="pubmed">32240279</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11:995&#x2013;998. doi: 10.1021/acschemneuro.0c00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer SL, Sharp WW, Weir EK. Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary Edema: therapeutic implications. Circulation. 2020;142:101&#x2013;104. doi: 10.1161/CIRCULATIONAHA.120.047915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047915</ArticleId><ArticleId IdType="pmc">PMC7363563</ArticleId><ArticleId IdType="pubmed">32369390</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur. J. Nucl. Med. Mol. Imag. 2020 doi: 10.1007/s00259-020-04973-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04973-x</ArticleId><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Verger A, Cammilleri S. PET imaging of COVID-19: the target and the number. Eur. J. Nucl. Med. Mol. Imaging. 2020;47:1636&#x2013;1637. doi: 10.1007/s00259-020-04820-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04820-z</ArticleId><ArticleId IdType="pmc">PMC7163172</ArticleId><ArticleId IdType="pubmed">32303786</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y-C, Bai W-Z, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020;92:552&#x2013;555. doi: 10.1002/jmv.25728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Sun T, Feng J. Complications and Pathophysiology of COVID-19 in the Nervous System. Front. Neurol. 2020;11:573421. doi: 10.3389/fneur.2020.573421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573421</ArticleId><ArticleId IdType="pmc">PMC7746805</ArticleId><ArticleId IdType="pubmed">33343486</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki NK, Lee L-Y. Mechanisms of dyspnea. Chest. 2010;138:1196&#x2013;1201. doi: 10.1378/chest.10-0534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-0534</ArticleId><ArticleId IdType="pmc">PMC2972628</ArticleId><ArticleId IdType="pubmed">21051395</ArticleId></ArticleIdList></Reference><Reference><Citation>Busana M, et al. Prevalence and outcome of silent hypoxemia in COVID-19. Minerva Anestesiol. 2021;87:325&#x2013;333. doi: 10.23736/S0375-9393.21.15245-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.21.15245-9</ArticleId><ArticleId IdType="pubmed">33694360</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am. J. Respir. Crit. Care Med. 2020;202:356&#x2013;360. doi: 10.1164/rccm.202006-2157CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202006-2157CP</ArticleId><ArticleId IdType="pmc">PMC7397783</ArticleId><ArticleId IdType="pubmed">32539537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasty F, et al. Heart rate variability as a possible predictive marker for acute inflammatory response in COVID-19 patients. Mil. Med. 2020 doi: 10.1093/milmed/usaa405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/milmed/usaa405</ArticleId><ArticleId IdType="pmc">PMC7717314</ArticleId><ArticleId IdType="pubmed">33206183</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet Lond. Engl. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Roumier M, et al. Tocilizumab for severe worsening COVID-19 pneumonia: a propensity score analysis. J. Clin. Immunol. 2020 doi: 10.1007/s10875-020-00911-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00911-6</ArticleId><ArticleId IdType="pmc">PMC7666405</ArticleId><ArticleId IdType="pubmed">33188624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Tang Y. Revisiting the immune balance theory: a neurological insight into the epidemic of COVID-19 and its alike. Front. Neurol. 2020;11:566680. doi: 10.3389/fneur.2020.566680.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.566680</ArticleId><ArticleId IdType="pmc">PMC7593407</ArticleId><ArticleId IdType="pubmed">33178109</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DP, et al. Heart rate variability and inflammation: A meta-analysis of human studies. Brain. Behav. Immun. 2019;80:219&#x2013;226. doi: 10.1016/j.bbi.2019.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.03.009</ArticleId><ArticleId IdType="pubmed">30872091</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen T, Christensen JH, Toft E, Schmidt EB. C-reactive protein is associated with heart rate variability. Ann. Noninvasive Electrocardiol. Off. J. Int. Soc. Holter Noninvasive Electrocardiol. Inc. 2007;12:216&#x2013;222. doi: 10.1111/j.1542-474X.2007.00164.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1542-474X.2007.00164.x</ArticleId><ArticleId IdType="pmc">PMC6931946</ArticleId><ArticleId IdType="pubmed">17617066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron C, et al. Impact of chronic treatment by &#x3b2;1-adrenergic antagonists on Nociceptive-Level (NOL) index variation after a standardized noxious stimulus under general anesthesia: a cohort study. J. Clin. Monit. Comput. 2021 doi: 10.1007/s10877-020-00626-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-020-00626-4</ArticleId><ArticleId IdType="pubmed">33398545</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>